Novartis Names Dr. Riad as new Managing Director and Country President
Aug 01, 2018
Dhaka, August 01, 2018: Dr. Riad Mamun Prodhani has recently been appointed as the Managing Director and Country President of Novartis (Bangladesh) Limited, the leading multinational pharmaceuticals of the country. With his new role, he also joins the Board of Directors of Novartis Bangladesh. Dr. Riad replaces Mr. Sheikh Nahar Mahmud who decided to retire earlier this year.
Dr. Riad brings more than 19 years of Sales, Marketing and General Management experience in the pharmaceutical industry home and abroad. Riad joined Novartis (Bangladesh) Limited in May 2017, serving most recently as the Country Head, Pharmaceuticals Division. Prior to Joining Novartis in 2017, he was the Managing Director, Country Chair and General Manager of Sanofi in Bangladesh and member of board of directors of Sanofi.
Dr. Riad graduated from Sir Salimullah Medical College and holds an MBA from IBA, Dhaka University. He also obtained two postgraduate degrees in Health Economics from the Institute of Health Economics, University of Dhaka.
Riad was an Executive Committee member of Bangladesh Association of Pharmaceuticals Industries (BAPI). He is also a member of BMDC (Bangladesh Medical and Dental Council), IBA Alumni Association and Old Remains Welfare Association.
About Novartis (Bangladesh) Ltd.
Novartis (Bangladesh) Limited operates as a subsidiary of Novartis AG, a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis (Bangladesh) Limited is a joint venture between Novartis AG (60%) and Bangladesh Chemical Industries Corporation (40%) of Government of People's Republic of Bangladesh. The company provides healthcare solutions specializing in research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Novartis operates businesses with global scale and strong customer ties, focusing on innovative patented medicines, generics and eye care devices. The Company exports its products to more than 55 countries in Europe, Asia, Africa and Latin America.